anaphylaxis
Information
- Disease name
- anaphylaxis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03953482 | Active, not recruiting | Evaluation of Medical Care and Patient's Knowledge About the Behavior to Take on Secondary Prevention of Anaphylaxis | October 16, 2018 | December 31, 2023 | |
| NCT03182491 | Active, not recruiting | Mechanisms of Anaphylaxis | April 28, 2017 | October 1, 2026 | |
| NCT00868842 | Completed | Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis | January 2009 | June 2012 | |
| NCT00890162 | Completed | Phase 2 | A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis | April 27, 2009 | May 31, 2019 |
| NCT01217138 | Completed | Phase 4 | Make up for the Epinephrine Autoinjector | June 2009 | May 2010 |
| NCT00047918 | Completed | Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing | October 2002 | August 2004 | |
| NCT00163735 | Completed | N/A | Potential Allergens in Wine: Double-blind Placebo-controlled Trial | August 2002 | May 2006 |
| NCT01361347 | Completed | Phase 4 | Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children | February 2008 | December 2016 |
| NCT01432522 | Completed | N/A | A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine | July 2010 | September 2011 |
| NCT02028065 | Completed | Phase 1 | A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101) | January 3, 2014 | July 1, 2014 |
| NCT02424136 | Completed | N/A | PEAnut Anaphylaxis Predictors | July 22, 2015 | December 2019 |
| NCT02854969 | Completed | N/A | Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device | May 2016 | July 18, 2017 |
| NCT02958605 | Completed | N/A | Smartphone Apps for Pediatric Resuscitation | November 2016 | September 2017 |
| NCT03282929 | Completed | Phase 1 | Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD) | March 23, 2017 | October 15, 2018 |
| NCT03366298 | Completed | Phase 4 | Pharmacokinetics of Intramuscular Adrenaline in Food--Allergic Teenagers | November 24, 2017 | October 2, 2018 |
| NCT03406325 | Completed | Mast Cell Activation Test in Allergic Disease | February 1, 2018 | December 1, 2019 | |
| NCT03942692 | Completed | What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction | May 21, 2019 | August 20, 2019 | |
| NCT04207840 | Completed | Phase 4 | Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals | December 9, 2019 | December 23, 2019 |
| NCT04290507 | Completed | Epidemiology and Outcome of Anaphylactic Shocks Admitted to Intensive Care Unit | January 1, 2017 | December 31, 2019 | |
| NCT04696822 | Completed | Phase 1 | Bioavailability of Nasal Epinephrine | November 1, 2020 | September 28, 2021 |
| NCT06205134 | Completed | Phase 1/Phase 2 | Comparative Bioavailability of Intranasal Epinephrine | August 22, 2023 | February 5, 2024 |
| NCT05135377 | Recruiting | Canadian Anaphylaxis Network- Predicting Recurrence After Emergency Presentation for Allergic REaction | April 11, 2022 | December 31, 2024 | |
| NCT05210543 | Recruiting | Acquisition and Long-term Observation of Patients With Severe Allergic Reactions | January 1, 2007 | December 2030 | |
| NCT06065137 | Recruiting | N/A | Standardised Drug Provocation Testing in Perioperative Hypersensitivity | October 23, 2023 | October 30, 2025 |
| NCT04615065 | Recruiting | Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine | September 1, 2020 | September 1, 2030 | |
| NCT04653324 | Recruiting | A Registry for the Food Allergy Community | August 24, 2017 | August 2027 | |
| NCT06445374 | Recruiting | Phase 1 | Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges | June 2024 | December 31, 2024 |
| NCT03523221 | Recruiting | Phase 1 | Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis | April 15, 2018 | September 2024 |
| NCT04755881 | Terminated | SHARED Study (Saguenay Hospitals Anaphylaxis Rule for Early Discharge) | December 3, 2019 | March 7, 2023 | |
| NCT02640014 | Unknown status | N/A | Oral Immunotherapy in Food Allergy in Finland | December 2015 | December 2021 |
| NCT04825158 | Unknown status | Study of the Role of Hemostasis in Perioperative Anaphylaxis | April 1, 2021 | February 9, 2024 | |
| NCT01326741 | Unknown status | Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis | March 2011 | ||
| NCT05112367 | Unknown status | Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Montpellier | October 1, 2021 | June 1, 2022 | |
| NCT01247415 | Unknown status | Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vaccine | January 2011 | November 2012 | |
| NCT01776489 | Unknown status | Evaluation of the Sphingolipid Metabolite S1P as a Novel Biomarker in Food Allergy | December 2011 | January 2017 | |
| NCT04475003 | Unknown status | Health Literacy Among Caregivers of Children With IgE-mediated Allergy With Risk of Anaphylaxis | September 30, 2020 | April 30, 2022 | |
| NCT00657228 | Withdrawn | N/A | Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department | December 2009 | December 2010 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000707